Multimodal Regional Brain Monitoring of Tissue Ischemia in Severe Cerebral Venous Sinus Thrombosis.


Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 26 2 2019
medline: 9 7 2020
entrez: 27 2 2019
Statut: ppublish

Résumé

Comatose critically ill patients with severe diffuse cerebral venous thrombosis (CVT) are at high risk of secondary hypoxic/ischemic insults, which may considerably worsen neurological recovery. Multimodal brain monitoring (MBM) may therefore improve patient care in this setting, yet no data are available in the literature. We report two patients with coma following severe diffuse CVT who underwent emergent invasive MBM with intracranial pressure (ICP), brain tissue oximetry (PbtO Despite effective therapeutic UFH (aPTT two times baseline levels in the two subjects), average CMD levels of lactate and glucose in the 6 h prior to EMT displayed evidence of regional brain ischemia. The EMT procedure was associated with a rapid (within 6 h) improvement in both CMD lactate (6.42 ± 0.61 4.89 ± 0.55 mmol/L, p = 0.02) and glucose (0.49 ± 0.17 vs. 0.96 ± 0.32 mmol/L, p = 0.0005). EMT was also associated with a significant increase in PbtO This study illustrates the potential utility of continuous bedside MBM in patients with coma after severe brain injury, irrespective of the primary acute cerebral condition. Despite adequate ICP and PbtO

Sections du résumé

BACKGROUND
Comatose critically ill patients with severe diffuse cerebral venous thrombosis (CVT) are at high risk of secondary hypoxic/ischemic insults, which may considerably worsen neurological recovery. Multimodal brain monitoring (MBM) may therefore improve patient care in this setting, yet no data are available in the literature.
METHODS
We report two patients with coma following severe diffuse CVT who underwent emergent invasive MBM with intracranial pressure (ICP), brain tissue oximetry (PbtO
RESULTS
Despite effective therapeutic UFH (aPTT two times baseline levels in the two subjects), average CMD levels of lactate and glucose in the 6 h prior to EMT displayed evidence of regional brain ischemia. The EMT procedure was associated with a rapid (within 6 h) improvement in both CMD lactate (6.42 ± 0.61 4.89 ± 0.55 mmol/L, p = 0.02) and glucose (0.49 ± 0.17 vs. 0.96 ± 0.32 mmol/L, p = 0.0005). EMT was also associated with a significant increase in PbtO
CONCLUSIONS
This study illustrates the potential utility of continuous bedside MBM in patients with coma after severe brain injury, irrespective of the primary acute cerebral condition. Despite adequate ICP and PbtO

Identifiants

pubmed: 30805844
doi: 10.1007/s12028-019-00695-7
pii: 10.1007/s12028-019-00695-7
doi:

Substances chimiques

Anticoagulants 0
Lactic Acid 33X04XA5AT
Heparin 9005-49-6
Glucose IY9XDZ35W2
Oxygen S88TT14065

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-303

Références

Filippidis A, Kapsalaki E, Patramani G, Fountas KN. Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus. 2009;27(5):E3.
doi: 10.3171/2009.8.FOCUS09167
Einhäupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010;17(10):1229–35.
doi: 10.1111/j.1468-1331.2010.03011.x
Ilyas A, Chen CJ, Raper DM, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J Neurointerv Surg. 2017;9:1086–92.
doi: 10.1136/neurintsurg-2016-012938
Aaron S, Alexander M, Moorthy RK, et al. Decompressive craniectomy in cerebral venous thrombosis: a single centre experience. J Neurol Neurosurg Psychiatry. 2013;84(9):995–1000.
doi: 10.1136/jnnp-2012-303356
Gala NB, Agarwal N, Barrese J, Gandhi CD, Prestigiacomo CJ. Current endovascular treatment options of dural venous sinus thrombosis: a review of the literature. J Neurointerv Surg. 2013;5(1):28–34.
doi: 10.1136/neurintsurg-2011-010117
Taniguchi S, Harada K, Kajihara M, Fukuyama K. Combined use of stent-retriever and aspiration thrombectomy for cerebral venous sinus thrombosis involving the straight sinus: a case report. Interv Neuroradiol. 2017;23(6):605–8.
doi: 10.1177/1591019917730335
Cabral de Andrade G, Lesczynsky A, Clímaco VM, et al. Cerebral venous sinuses thrombosis in both transverse sinus and torcula: multistep endovascular treatment and stenting. Interv Neuroradiol. 2017;23(1):84–9.
doi: 10.1177/1591019916674917
Coutinho JM, Ferro JM, Zuurbier SM, et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke. 2013;8(2):135–40.
doi: 10.1111/j.1747-4949.2011.00753.x
Yakovlev SB, Bocharov AV, Mikeladze K, Gasparian SS, Serova NK, Shakhnovich AR. Endovascular treatment of acute thrombosis of cerebral veins and sinuses. Neuroradiol J. 2014;27(4):471–8.
doi: 10.15274/NRJ-2014-10066
Zhang S, Hu Y, Li Z, et al. Endovascular treatment for hemorrhagic cerebral venous sinus thrombosis: experience with 9 cases for 3 years. Am J Transl Res. 2018;10(6):1611–9.
pubmed: 30018704 pmcid: 6038069
Wakerley B, Yohana K, Luen Teoh H, Tan CW, Chan BP, Sharma VK. Non-invasive intracranial pressure monitoring with transcranial Doppler in a patient with progressive cerebral venous sinus thrombosis. J Neuroimaging. 2014;24(3):302–4.
doi: 10.1111/j.1552-6569.2012.00745.x
Valdueza JM, Hoffmann O, Weih M, Mehraein S, Einhäupl KM. Monitoring of venous hemodynamics in patients with cerebral venous thrombosis by transcranial Doppler ultrasound. Arch Neurol. 1999;56(2):229–34.
doi: 10.1001/archneur.56.2.229
Wall J, Enblad P. Neurointensive care of patients with cerebral venous sinus thrombosis and intracerebral haemorrhage. J Clin Neurosci. 2018;58:83–8.
doi: 10.1016/j.jocn.2018.10.003
Armonda RA, Vo AH, Bell R, Neal C, Campbell WW. Multimodal monitoring during emergency hemicraniectomy for vein of Labbe thrombosis. Neurocrit Care. 2006;4(3):241–4.
doi: 10.1385/NCC:4:3:241
Frontera J, Ziai W, O’Phelan K, et al. Regional brain monitoring in the neurocritical care unit. Neurocrit Care. 2015;22(3):348–59.
doi: 10.1007/s12028-015-0133-x
Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664–70.
doi: 10.1161/01.STR.0000117571.76197.26
Ferro JM, Bousser MG, Canhão P, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis—endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203–13.
doi: 10.1111/ene.13381
Wang W, Lin C, Hong J, Wang S, Gu J. Effects of increased intracranial pressure gradient on cerebral venous infarction in rabbits. World Neurosurg. 2018;120:e161–8.
doi: 10.1016/j.wneu.2018.07.264
Soyer B, Rusca M, Lukaszewicz AC, et al. Outcome of a cohort of severe cerebral venous thrombosis in intensive care. Ann Intensive Care. 2016;6(1):29.
doi: 10.1186/s13613-016-0135-7
Borhani Haghighi A, Mahmoodi M, Edgell RC, et al. Mechanical thrombectomy for cerebral venous sinus thrombosis: a comprehensive literature review. Clin Appl Thromb Hemost. 2014;20(5):507–15.
doi: 10.1177/1076029612470968
Li G, Zeng X, Hussain M, et al. Safety and validity of mechanical thrombectomy and thrombolysis on severe cerebral venous sinus thrombosis. Neurosurgery. 2013;72(5):730–8.
doi: 10.1227/NEU.0b013e318285c1d3
Lee DJ, Ahmadpour A, Binyamin T, Dahlin BC, Shahlaie K, Waldau B. Management and outcome of spontaneous cerebral venous sinus thrombosis in a 5-year consecutive single-institution cohort. J Neurointerv Surg. 2017;9(1):34–8.
doi: 10.1136/neurintsurg-2015-012237
Gura M, Elmaci I, Sari R, Coskun N. Correlation of pulsatility index with intracranial pressure in traumatic brain injury. Turk Neurosurg. 2011;21(2):210–5.
pubmed: 21534204

Auteurs

Alexandre Simonin (A)

Neurosurgery, Department of Clinical Neurosciences, University Hospital of Lausanne (CHUV), Rue du Bugnon 21, Lausanne, Switzerland. alexandresimonin21@gmail.com.

Marco Rusca (M)

Department of Intensive Care Medicine, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Guillaume Saliou (G)

Neuroradiology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Marc Levivier (M)

Neurosurgery, Department of Clinical Neurosciences, University Hospital of Lausanne (CHUV), Rue du Bugnon 21, Lausanne, Switzerland.

Roy Thomas Daniel (RT)

Neurosurgery, Department of Clinical Neurosciences, University Hospital of Lausanne (CHUV), Rue du Bugnon 21, Lausanne, Switzerland.

Mauro Oddo (M)

Department of Intensive Care Medicine, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH